Global Market Study on HbA1c Analyzers: Precision and Reliability Emerge as Differentiating Factors


Hba1c Analyzers  Market
  • Published On : Jul-2019 |
  • Pages : 227 Pages |
  • Format :

HbA1c Analyzers Market – Introduction

Persistence Market Research (PMR) recently published a report on HbA1c analyzers market with a comprehensive analysis for the historical period 2014-2018 and forecast period 2019-2029. The business asset offers an in-depth analysis of the growth of the HbA1c analyzers market, and its influence on the key stakeholders.

The study also offers a detailed outlook on the macroeconomic and microeconomic factors that influence the growth of the HbA1c analyzers market over the course of the forecast period. The report studies the key drivers, restraints, opportunities, and threats that govern the growth of the HbA1c analyzers market.

This detailed study focuses on the Y-o-Y growth trend and absolute $ opportunity. Key findings, trends, and recent developments that can impact the HbA1c analyzers market size are also included in this research report.

The HbA1c analyzers market has been analyzed in terms of value (US$ Mn) and volume (Units). The report also offers crucial information on the market structure, in order to equip the stakeholders of the HbA1c analyzers market with an incisive view of the competitive landscape. The research report profiles key players of the HbA1c analyzers market, along with their strategies, products, and financials.

HbA1c Analyzers Market – Segmentation

In order to present the impact of the crucial aspects, our analysts have formed key segments of the HbA1c analyzers market. The market has been segmented based on the product type, technology, modality, end user, and region. The report studies these segments in detail and offers reliable statistics and data regarding the growth of the HbA1c analyzers market.

Product Type

Technology

Modality

End User

Region

Equipment

Ion Exchange Chromatography

Portable HbA1c Analyzers

Hospitals

North America

Reagents & Consumables

Boronate Affinity HPLC

Benchtop HbA1c Analyzers

Diagnostic Centers

Latin America

HPLC

Academic and Research Institutes

Europe

Boronate Affinity Technology

South Asia

East Asia

Oceania

MEA

HbA1c Analyzers Market – Key Questions Answered

The study on HbA1c analyzers market highlights distinguished and rare insight, in order to help the stakeholders gain exclusive information. Our analysts have answered numerous questions encircling the HbA1c analyzers market. Some of the questions answered in the report include:

  • What is the structure of the HbA1c analyzers market?
  • What are the key trends observed in the HbA1c analyzers market?
  • What are the significant challenges that could hamper the growth of the HbA1c analyzers market?
  • What are the key strategies employed by the stakeholders of the HbA1c analyzers market?
  • Which end user will witness high adoption of HbA1c analyzers during the forecast period?
  • Which modality type will spectate high sales during the forecast period?
  • Which the most lucrative region for HbA1c analyzers market?

HbA1c Analyzers Market – Research Methodology

A systematic approach has been followed to draw crucial insights into the HbA1c analyzers market. Analysts at PMR follow a top-bottom and bottom-top approach to assess the HbA1c analyzers market and validate the information obtained from the primary as well as the secondary research methodology. In order to conduct primary research, interviews with a number of technology developers, distributors, manufacturers, key opinion leaders, and market heads were conducted.

Through the primary research, information about the key drivers and restraints, opportunities, winning strategies, regional value split, anticipated growth projections, and market concentrations has been acquired. In order to carry out secondary research, analysts at PMR studied numerous sources using essential sources. Some of the secondary sources include company websites, company annual reports, White papers, and financial reports. The paid publications that were referred to include BVD, Morningstar, Meltwaters, Genios, GBI, and Factiva. Through secondary research, information about the market share by region, industry growth projections, key insights on market segments, trends, and opportunities, can be obtained.

Precision and Time-efficiency - The USP of HbA1c Analyzers

The use of advanced equipment and medical devices continues to gain ground in the healthcare industry. With a long-term focus on early diagnosis and preventive healthcare, new devices are seeing the light of the day, whereas legacy equipment is witnessing a massive upgrade.

Glycated Hemoglobin, also known as HbA1c analyzers, are one such diagnostic equipment with competence to offer faster results than their traditional equivalents. As the high prevalence of diabetes poses tough questions to policymakers and healthcare industry, the focus has shifted to implementing robust and holistic methodologies that can offer incremental, yet long-term solutions.

Sensing the lucrative opportunities, Persistence Market Research (PMR), in its latest study, identifies crucial and distinguished insights for the period 2019-2029. A comprehensive analysis of this market has been offered to the readers, and a thorough evaluation of respective market positioning has been curated to reflect the dynamics of the competitive landscape.  

HbA1c Analyzers Market Strategy

Tracing the Evolution of the HbA1c Analyzers Market

HbA1c analyzers, now spectating an established spot in diagnostic centers, hospitals, and academic and research institutes, have come a long way from the time they were first proposed in 1976. High prevalence of diabetes among geriatric population and people leading a demanding lifestyle have necessitated the shift towards effective glycated hemoglobin analyzers to assess the glucose metabolism in diabetic patients. Over a period of time, sales picked up, and as recent as 2018, the HbA1c analyzers market registered a value of US$ 1,538 Mn.

As technology enables further advancement, precision and time-efficiency become the real USP of HbA1c analyzers. With the edges of fasting plasma glucose, HbA1c analyzers manufacturers are relying on research and development activities to nullify the effects of variables and offer high sample throughput per hour.

In a landscape, where convenience of usage plays a pivotal role, the development of portable analyzers will remain a significant driver in the future. However, the inefficiency of HbA1c analyzers to offer an accurate analysis for pregnant and elderly population continues to pose challenges.

HbA1c Analyzers Market North America

Manufacturer Reliance on Diagnostic Center Sales Remains High

The surge in the demand for Hb1Ac analyzers can be attributed to the high preference of end users for reagents and consumables, owing to the growing need for routine diabetes checkups. High prevalence of diabetes and the inconvenience caused to patients with frequent hospital trips, in turn, increase their adoption rate at point-of-care centers. When purchased in bulk, expenditures on laboratory supplies can be controlled, which generates high sales opportunities from the diagnostic centers.

The adoption of HbA1c analyzers is high in the diagnostic centers as they offer faster results, which can further lead to the quick initiation of treatment procedures and improve the mortality rates. However, HbA1c analyzers continue to spectate high demand from hospitals to test the glucose level in patients prior to surgeries.

Stringent scrutiny of healthcare equipment and technological leaps in the US has enhanced the quality of HbA1c analyzers, which has been influencing their sales in hospitals, diagnostic centers, and academic and research institutes. A large number of hospitals and diagnostic centers, in turn, direct to the high sales closure opportunities in the region. However, developing countries of Asia Pacific, Middle East, and Africa are likely to remain opportunistic for vendors operating in the HbA1c analyzers market.

Analyzing Winning Opportunities for the HbA1c Analyzer Vendors

Focus on Increasing Sales through Diagnostic Centers

Among the other end users, diagnostic centers remain at the forefront of the demand for HbA1c analyzers, as they are cost-effective, convenient for patients, and offer quicker results. Manufacturers can cash in on the high adoption of HbA1c analyzers in diagnostic centers by entering into long-term partnerships. The customer relationship will help them in identifying the gaps between their products and the use case, which they can bridge by leveraging R&D activities.

Leverage R&D Activities to Target Custom Demand

As competition remains high, manufacturers are expending their efforts to cater to specific consumer demands. With over 300 analytical methods present in the healthcare industry, the selection of HbA1c analyzers highly depends on their availability, cost, ease of use, and precision. As end users seek convenient equipment, portability can be a determiner in sales closure. Additionally, manufacturers can focus on increasing the sample throughput of HbA1c analyzers.

Channelize the Distribution of HbA1c Analyzers

Though the adoption of HbA1c analyzers is high in developed regions like North America and Europe, owing to their early technological switch and presence of tech-savvy patients, sales are yet to peak in developing countries. Unmet needs of highly populous countries in Asia Pacific and lack of sophisticated healthcare infrastructure in the Middle East and Africa can create significant sales opportunities for HbA1c analyzer manufacturers.

HbA1c Analyzers Market – Competitive Landscape

The HbA1c analyzers market can be characterized by the presence of numerous global, regional, and local players. Pricing, product innovation, technological prowess, and geographical reach remain the key focus areas of these players. Prevalence of high competition in the HbA1c analyzers market creates a narrow passage for new players.

The leading players stay ahead of the supply curve by targeting specific demands ascending from end users. These leading players account for ~60% of the global market:

  • F.Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.

In the business journey, the global players work on building robust customer relationship, which helps them direct their research and development efforts in catering to their niche demands. In addition, their focus of interest lies in forming a partnership with research academies and public healthcare institutions. For instance, in July 2017, Abbott and Bigfoot Biomedical entered into an agreement to develop diabetes management systems by converging Abbott’s Freestyle with Bigfoot’s insulin delivery solutions in the United States.

The regional players, however, compete with their global contenders on the basis of pricing and precision of products. These players account for ~22% of market share and their utmost focus lies on the development of point-of-care and central laboratory technology. For instance, Zivak Technologies launched a product –HB-100 HbA1c/Variant Analyzer for the accurate determination of stable HbA1c that has a high pressure gradient with dual HPLC pump and has a low maintenance cost.

hba1c analyzers market segmentation

Analysts’ Take on the HbA1c Analyzers Market

The author(s) of the report highlights that the HbA1c analyzers market will grow at a steady rate during the forecast period with a CAGR of ~5%. An investment in benchtop HbA1c analyzers will offer high returns, as compared to the portable ones. Vendors who work on enhancing the precision of analyzers, along with the focus on price will be able to safeguard their position in the HbA1c analyzers market.

Asia Pacific and the Middle East and Africa will surface new opportunities for the growth of the HbA1c analyzers market, which if picked up can help expand the clientele base. Vendors can capitalize on the high demand generated by diagnostic centers to have better chances at sales closures. Acquisition and merger activities will remain a key strategy to bigfoot the regional markets with low infiltration of HbA1c analyzers. However, variations in the test results are likely to slow down the proliferated adoption of HbA1c analyzers, which remains a challenge for the market vendors to tackle.

Read More

Increasing prevalence of diabetes expected to boost the HbA1c Analyzers and Reagent market

The increasing prevalence of diabetes is one of the main factors responsible for the growth of HbA1c analyzers and reagent market. Global sales are likely to reach approximately US$ 2 Bn by the end of 2029.

The prevalence of diabetes is expected to increase exponentially worldwide, which can be attributed to the increasing prevalence of diabetes, changes in lifestyle, and various other factors such as malnutrition, genetic mutations, etc.

Obesity is one of the main risk factors that lead to diabetes. According to World Health Organization, the prevalence of diabetes has been rising more rapidly in middle- and low-income countries.

According to various government and private organizations operating in the diabetes industry, diabetes is considered one of the most fatal diseases. For instance, according to the American Diabetes Association, diabetes accounts for approximately 71,000 deaths in the U.S. each year.

According to the International Diabetes Federation, in 2015, 415 million people worldwide were living with diabetes, and it is predicted that by 2040, more than 10% of the world’s adult population or around 642 million people will suffer from diabetes.

Increasing geriatric population expected to drive the HbA1c analyzers and reagent market

Increasing geriatric population is one of the most important factors that is expected to increase the overall growth of the HbA1c analyzers and reagent market. Geriatric population across the globe is growing considerably and hence, metabolic disorders are increasing among the people, which is leading to the high risk of diabetes.

According to CDC, the prevalence of diabetes was found to be the highest in population aged between 65 and 74 years, which was 21.5% of the total U.S. population in 2014.

Japan has one of the fastest growing aging populations in the world. Ministry of Internal affairs and Communications (MIC) announced in 2013 that the number of people aged over 65 had exceeded 30.4 Mn and constituted 24% of the total population.

Advantages of HbA1c analyzers over laboratory measurement of fasting plasma glucose likely to boost the HbA1c analyzers market

There are many advantages of HbA1c analyzers over the standard equipment used for measuring fasting plasma glucose, which is another factor that is expected to increase the growth of the Hba1c analyzers market.

The measurement of glucose in the plasma of fasting subjects is accepted as a standard way of measuring the sugar level. However, there are various limitations associated with the measurement of fasting plasma glucose, which include biological variation, preanalytical variation, analytical variation, etc. Analytical variation, such as less accuracy of measurement, is also a serious problem that can lead to wrong measurements, and this is another factor contributing to the significant growth of the HbA1c analyzers market.

The HbA1C assay leads to the precise and accurate measurement of chronic glycemic levels and correlates with the risk of diabetes complications. HbA1c is very convenient for patients and provides more accurate results. Hence, the adoption of HbA1c is expected to increase in the upcoming years.  

Competitive Landscape

The competition section of the report features profiles of the key players operating in the HbA1c analyzers market based on their market shares, development strategies, product line, marketing strategy, and company dashboard. Examples of some of the key players featured in this report

  • ARKRAY, Inc.
  • Bio-Rad Laboratories, Inc.
  • Trinity Biotech Plc.
  • Siemens Healthcare Private Limited
  • HemoCue AB
  • EKF Diagnostics,
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories.

Request Information on the HbA1c Analyzers Market Competitive Landscape

Definition

HbA1c analyzers are used for measuring the concentration of hemoglobin in the blood or in urine sample. There are two types of Hba1c analyzers – portable HbA1c analyzers and benchtop HbA1c analyzers. HbA1c analyzers work on different technologies such as high-performance liquid chromatography, ion exchange chromatography, boronate affinity, high-performance liquid chromatography, and boronate affinity technology.

About the Report

PMR has conducted a research study on the HbA1c analyzers market for the forecast period 2019 to 2029. The HbA1c analyzers market report offers a comprehensive evaluation of the business opportunities prevailing in the HbA1c analyzers market, along with insights on the HbA1c analyzers current trends and their multiple applications. The report elaborates the macroeconomic factors that influence the dynamics of HbA1c analyzers market and its futuristic potential.

Segmentation

The report offers a comprehensive taxonomy of the HbA1c analyzers market based on product type, technology, modality, end users, and region. There are two types of HbA1c analyzers: portable HbA1c analyzers and benchtop Hba1C analyzers, which are majorly used in the HbA1c analyzers market. Benchtop HbA1c analyzers are expected to hold a large revenue share in the HbA1c analyzers market. Based on the product type, the HbA1c analyzers market has been segmented into equipment and reagent & consumables. Reagent and consumables are expected to hold a large revenue share in the HbA1c analyzers market. Hba1c analyzers work on different technologies, which include ion exchange chromatography, boronate affinity chromatography, high-performance liquid chromatography, and boronate affinity technology. Based on the end user, the HbA1c analyzers market has been segmented into hospitals, diagnostic centers, and academic & research institutes. The HbA1c analyzers market has been analyzed across various regions, namely North America, Latin America, Europe, East Asia, South Asia Oceania, and Middle East and Africa.

Additional Questions Answered

Some of the additional questions addressed in this report on the HbA1c analyzers market-

  • What is the revenue potential of the HbA1c analyzers market across North America and Europe?
  • Who are the key competitors and what are their portfolios in the HbA1c analyzers market?
  • What are major challenges influencing the growth of the HbA1c analyzers market?
  • How intervention from regulatory authority is shaping the growth of the HbA1c analyzers market?

For answers of all the possible questions required for gauging performance of the HbA1c analyzers market, get in touch with our expert analyst.

Research Methodology

The HbA1c analyzers market has been estimated based on the supply-demand approach. A triangulation methodology has been adopted to derive the market size, which is based on the capital equipment installed base to obtain precise market estimations and insights on diagnostic devices based on technology, modality, and basic product features. 

The information about the installation of HbA1c analyzers, mainly in hospitals, is further validated through primary research (by conducting surveys and interviews) and secondary research (including company websites, annual reports, and resourceful databases). With this approach, the report on the HbA1c analyzers market projects the industry attractiveness of every major segment over the forecast period.

Company Profiles: 

  • Abbott
  • ApexBio
  • ARKRAY, Inc.
  • Bio-Rad Laboratories, Inc.
  • Convergent Technologies GmbH & Co. KG
  • EKF Diagnostics
  • Erba Mannheim
  • F. Hoffmann-La Roche Ltd
  • HemoCue AB
  • i-SENS, Inc.
  • labONE, Inc.
  • LITE-ON TECHNOLOGY CORPORATION
  • Meril Life Sciences Pvt. Ltd.
  • OSANG Healthcare
  • TaiDoc Technology Corporation
  • Tosoh Corporation
  • Trinity Biotech
  • Zivak Technologies USA
Back To Top